EBI3 and neoplasm: Nevertheless, the upregulation of EBI3 expression is highly associated with tumor progression and metastasis in a variety of cancers including breast (58), gastric (64), lung (44), pancreatic (65), cervical (66), and nasopharyngeal (67) cancers.